HOOKIPA Pharma
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. HOOKIPA Pharma's past years’ income statements indicate that its last revenue has increased compared to the previous period by 41% to $20,129,000. Profit margin reached -405%. Total operating expenses were $117,823,000.

Profit Margin

HOOKIPA Pharma Inc. (NASDAQ:HOOK): Profit margin
2017 0 -12.72M
2018 7.62M -16.23M -212.83%
2019 11.94M -34.14M -285.94%
2020 19.58M -44.08M -225.09%
2021 18.44M -75.66M -410.16%
2022 14.24M -65.14M -457.19%
2023 20.12M -81.58M -405.29%

HOOK Income Statement (2017 – 2023)

2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue
20.12M14.24M18.44M19.58M11.94M7.62M0
Cost of revenue
3.55M3.60M4.64M53.13M46.31M0398K
Gross profit
16.57M10.64M13.80M-33.54M-34.37M7.62M-398K
Operating exp.
Research and development
86.42M68.64M82.85M54.78M46.31M21.96M9.77M
Selling and marketing
0000000
Total operating expenses
117.82M87.40M100.12M72.86M63.02M23.19M12.08M
Operating income
-97.69M-73.15M-81.67M-53.28M-51.08M-21.18M-14.15M
Other income (expenses), net
16.48M8.24M6.00M9.20M8.04M133K1.43M
Income before tax
-81.21M-64.91M-75.66M-44.08M-43.03M-16.21M-12.71M
Income tax expense
368K230K1K-10.28M-8.89M24K4K
Net income
-81.58M-65.14M-75.66M-44.08M-34.14M-16.23M-12.72M
Earnings per share
Basic EPS
-8.63-0.99-2.3-16.9-1.91-0.99-0.78
Diluted EPS
-8.63-0.99-2.3-16.9-1.91-0.99-0.78
Data sourceData sourceData sourceData sourceData source